Facebook Pixel Stagflation for the ages | Financial Express Hyderabad – newspaper – Lesen Sie diese Geschichte auf Magzter.com
Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

Stagflation for the ages

Financial Express Hyderabad

|

April 26, 2025

EARLY FIVE YEARS ago, I warned that stagflation was only a broken supply chain away.

- STEPHEN S ROACH

A temporary outbreak did indeed occur in the immediate aftermath of the Covid-19 shock, as a surge in inflation coincided with an anaemic recovery in global demand. But, like the pandemic, that economic disruption quickly subsided. Today, a more worrisome form of stagflation is in the offing, threatening severe and lasting consequences for the global economy and world financial markets.

An important difference between these two strains of stagflation is the nature of the damage. During the pandemic, supply chains were stressed by significant demand shifts — during early lockdowns, people consumed more goods and fewer services, with a sharp reversal taking place after reopening. This led to soaring commodity prices, semiconductor shortages, and global shipping bottlenecks, which collectively accounted for about 60% of the surge in US inflation in 2021-22. It took roughly two years for those supply-chain disruptions to begin to fade, allowing inflationary pressures to ease.

Such temporary disruptions now seem almost quaint compared to the fundamental reordering of global supply chains sparked by US President Donald Trump's "America First" protectionism. The United States, for all intents and purposes, is disengaging, or decoupling, from global trade networks, especially from China-centric supply chains in Asia and potentially even from the supply chains that knit together North America through the US-Mexico-Canada Agreement, the so-called "gold standard" of trade agreements.

WEITERE GESCHICHTEN VON Financial Express Hyderabad

Financial Express Hyderabad

US deal alone can’t ease global turmoil: FM

SHEADDED THAT

time to read

1 mins

February 24, 2026

Financial Express Hyderabad

US-based The Cheesecake Factory enters India

THE CHEESECAKE FACTORY

time to read

1 min

February 24, 2026

Financial Express Hyderabad

Fraud impact likely to be limited: IDFC First

EMPLOYEES SUSPENDED; KPMG TO DO FORENSIC AUDIT

time to read

2 mins

February 24, 2026

Financial Express Hyderabad

Bitcoin slides below $65K amid tariff woes

BITCOIN BRIEFLY SLID below $65,000 on Monday for the second time this month, roiled by uncertainty over the status of US tariffs.

time to read

1 min

February 24, 2026

Financial Express Hyderabad

GDP likely grew 7.35% in Q3: FE poll

INDIA'S ECONOMY LIKELY recorded a growth rate of around 7.35% in the October-December quarter (Q3) of FY26, according to a Financial Express poll of economists.

time to read

2 mins

February 24, 2026

Financial Express Hyderabad

Lenskart to focus on margin-led growth

ANTICIPATES 25% REVENUE, 53% EBITDA CAGR DURING FY25-28

time to read

1 mins

February 24, 2026

Financial Express Hyderabad

Renault to take full control of Flexis

RENAULT WILL BUY out truckmaker Volvo Group’s and shipping firm CMA CGM’s stakes in their new-generation electric vans joint venture Flexis, the French carmaker said on Monday.

time to read

1 min

February 24, 2026

Financial Express Hyderabad

ABB India upbeat on capex

THE FIRM’S ELECTRIFICATION SEGMENT SEES A RISE IN EXPORT REVENUES

time to read

2 mins

February 24, 2026

Financial Express Hyderabad

Over-disclosures as problematic as non-disclosures: Sebi WTM

WHEN KEY RISKS of a company are buried in dense and vaguely-framed documents, over-disclosures can be as problematic as non-disclosures, Sebi Whole Time Member Amarjeet Singh said on Monday.

time to read

1 min

February 24, 2026

Financial Express Hyderabad

Centre reopens PLI scheme for key bulk drugs

THE GOVERNMENT HAS reopened applications under the performance-linked incentive (PLI) scheme for the production of two critical bulk drugs: the broad-spectrum antibiotic meropenem and the antiretroviral medicine ritonavir.

time to read

1 min

February 24, 2026

Listen

Translate

Share

-
+

Change font size